Hosted on MSN5h
William Blair Upgrades Tempur Sealy International (TPX)
Fintel reports that on February 5, 2025, William Blair upgraded their outlook for Tempur Sealy International (NYSE:TPX) from ...
What is William Blair’s Forecast for TWST Q2 Earnings?
Research analysts at William Blair issued their Q2 2026 earnings per share (EPS) estimates for Twist Bioscience in a report ...
William Blair Expects Reduced Earnings for Sera Prognostics
Equities researchers at William Blair cut their Q3 2025 earnings estimates for Sera Prognostics in a report released on Monday, February 3rd. William Blair analyst A. Brackmann now expects that the ...
Mersana Therapeutics initiated with an Outperform at William Blair
William Blair initiated coverage of Mersana Therapeutics (MRSN) with an Outperform rating.Maximize Your Portfolio with Data Driven ...
Investor's Business Daily on MSN9h
Viking Therapeutics Plummeted 10% On Its Earnings Report. Here's Why.
Viking Therapeutics stock plunged late Wednesday on an earnings report that included mostly incremental updates for its ...
FiercePharma16h
Astellas takes $760M charge, reveals slowdown for eye drug Izervay after regulatory stumbles
Navigating regulatory hurdles in the U.S. and Europe, plus fierce competition from rival Apellis, Astellas’ geographic ...
Karman Holdings seeks up to $2.6 billion valuation in US IPO
Karman Holdings, backed by Trive Capital, said on Wednesday that it is targeting a valuation of up to $2.6 billion in its New ...